Insys Therapeutics Quick Ratio (INSY) starting from the first quarter 2019 to first quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Insys Therapeutics, Inc.  (INSY)

Insys Therapeutics's Quick Ratio

INSY's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the first quarter 2019, Quick Ratio fell to 0.43 below Insys Therapeutics, Inc. average.

Within Major Pharmaceutical Preparations industry 420 other companies have achieved higher Quick Ratio than Insys Therapeutics in first quarter 2019. While Quick Ratio total ranking in the first quarter 2019 has deteriorated compared to the prior quarter from 2204 to 2674.

Explain Quick Ratio?
How much Cash & cash equivalents INSY´s has?
What are INSY´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INSY Quick Ratio (Mar 31 2019)
Q1		 (Dec 31 2018)
Q4		 (Sep 30 2018)
Q3		 (Jun 30 2018)
Q2		 (Mar 31 2018)
Q1
Y / Y Current Liabilities Change -1.31 % -50.29 % 1.18 % 219.7 % 219.77 %
Y / Y Cash & cash equivalent Change -26.7 % -62.2 % -17.33 % -25.92 % -26.3 %
Quick Ratio MRQ 0.43 0.9 0.48 0.52 0.58
INSY's Total Ranking # 2674 # 2204 # 2279 # 1818 # 2353
Seq. Current Liabilities Change 82.68 % -49.44 % 4.83 % 1.92 % -7.98 %
Seq. Cash & cash equivalent Change -12.32 % -4.86 % -4.14 % -8.34 % -54.78 %



Quick Ratio first quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 421
Healthcare Sector # 736
Overall Market # 2674


Quick Ratio Statistics
High Average Low
2.51 1.45 0.01
(Mar 31 2017)   (Mar 31 2013)




Financial Statements
Insys Therapeutics's Current Liabilities $ 195 Millions Visit INSY's Balance sheet
Insys Therapeutics's Cash & cash equivalent $ 84 Millions Visit INSY's Balance sheet
Source of INSY's Sales Visit INSY's Sales by Geography


Cumulative Insys Therapeutics's Quick Ratio

INSY's Quick Ratio for the trailling 12 Months

INSY Quick Ratio

 (Mar 31 2019)
12 Months		 (Dec 31 2018)
12 Months		 (Sep 30 2018)
12 Months		 (Jun 30 2018)
12 Months		 (Mar 31 2018)
12 Months
Y / Y Current Liabilities TTM Growth 4.43 % 30.77 % 100.21 % 192.53 % 135.34 %
Y / Y Cash & cash equivalent TTM Growth -38.96 % -38.12 % -12.72 % -15.68 % -12.54 %
Quick Ratio TTM 0.54 0.58 0.69 0.72 0.92
Total Ranking TTM # 5092 # 4649 # 1990 # 1765 # 5080
Seq. Current Liabilities TTM Growth -0.36 % -13.09 % 0.3 % 20.23 % 24.77 %
Seq. Cash & cash equivalent TTM Growth -7.35 % -27.47 % -3.55 % -5.82 % -6.08 %

Quick ratio ranking by company, industry and sector >> Back to INSY Financial Strength Comparisons >> Go to Compare INSY Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in INSY's Current Liabilities to $195.22 millions, cumulative Quick Ratio to 0.54 below the INSY average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 460 other companies have achieved higher Quick Ratio than Insys Therapeutics. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2018 from 4649 to 5092.

Explain Quick Ratio?
How much Cash & cash equivalents INSY´s has?
What are INSY´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 461
Healthcare Sector # 904
Within the Market # 5092


trailing twelve months Quick Ratio Statistics
High Average Low
2.28 1.51 0.53
(Mar 31 2017)   (Sep 30 2018)




Companies with similar Quick Ratio in the quarter ending Mar 31 2019, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2019 MRQ Cash & cash equivalentMar 31 2019 MRQ Current Liabilities
Stablecoin Development Corporation  1.15 $ 2.932  Millions$ 2.554  Millions
Lannett Company Inc  1.15 $ 205.207  Millions$ 178.922  Millions
Bristol myers Squibb Company  1.13 $ 9,997.000  Millions$ 8,841.000  Millions
Medicure Inc   1.11 $ 9.931  Millions$ 8.933  Millions
Athenex Inc   1.10 $ 71.344  Millions$ 64.680  Millions
Oncolytics Biotech Inc   1.10 $ 10.837  Millions$ 9.858  Millions
Akebia Therapeutics Inc   1.10 $ 168.038  Millions$ 153.029  Millions
Vaccinex Inc   1.10 $ 7.627  Millions$ 6.959  Millions
Akorn Inc  1.09 $ 184.090  Millions$ 168.786  Millions
Trillium Therapeutics Inc   1.08 $ 14.584  Millions$ 13.527  Millions
Omeros Corporation  1.06 $ 47.222  Millions$ 44.505  Millions
9 Meters Biopharma Inc   1.06 $ 11.570  Millions$ 10.944  Millions
Chembio Diagnostics Inc   1.01 $ 7.371  Millions$ 7.296  Millions
Xenetic Biosciences Inc   1.01 $ 2.018  Millions$ 2.006  Millions
Ironwood Pharmaceuticals inc   1.00 $ 119.045  Millions$ 118.569  Millions
Relmada Therapeutics Inc  0.96 $ 2.054  Millions$ 2.130  Millions
Organogenesis Holdings Inc   0.96 $ 30.561  Millions$ 31.912  Millions
Citius Pharmaceuticals Inc   0.95 $ 3.201  Millions$ 3.361  Millions
Notable Labs Ltd   0.95 $ 8.255  Millions$ 8.728  Millions
Metavia Inc   0.95 $ 1.618  Millions$ 1.712  Millions
Melinta Therapeutics, Inc.  0.90 $ 116.901  Millions$ 129.961  Millions
Mereo Biopharma Group Plc  0.90 $ 35.525  Millions$ 39.645  Millions
Zyla Life Sciences  0.89 $ 36.785  Millions$ 41.334  Millions
Zevra Therapeutics Inc   0.89 $ 13.438  Millions$ 15.172  Millions
Axim Biotechnologies Inc   0.84 $ 2.837  Millions$ 3.390  Millions
Can fite Biopharma Ltd   0.82 $ 2.697  Millions$ 3.271  Millions
Dmk Pharmaceuticals Corporation  0.81 $ 9.190  Millions$ 11.397  Millions
Johnson and Johnson  0.78 $ 15,336.000  Millions$ 19,588.000  Millions
Neos Therapeutics Inc   0.78 $ 39.965  Millions$ 51.285  Millions
Theratechnologies Inc   0.77 $ 28.661  Millions$ 37.144  Millions

Date modified: 2026-09-12T06:13:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.